Serum free light chains and multiple myeloma: Is it time to extend their application?

In nonsecretory, oligo‐secretory, and light chain multiple myeloma patients, serial sFLC evaluation could precede biochemical and clinical disease progression, even in extramedullary relapse, thus initiating early treatment with novel anti‐MM agents.

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Case Rep
Autors principals: Markovic, Uros, Leotta, Valerio, Tibullo, Daniele, Giubbolini, Rachele, Romano, Alessandra, Del Fabro, Vittorio, Parrinello, Nunziatina Laura, Cannizzaro, Maria Teresa, Di Raimondo, Francesco, Conticello, Concetta
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Case Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7141730/
https://ncbi.nlm.nih.gov/pubmed/32274022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2636
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars